Resistin, frequently elevated in obesity, promotes neuroinflammation, disrupts insulin signaling, and accelerates β-amyloid (Aβ) deposition and tau pathology. The gene discussed is MAPT; the disease is obesity due to melanocortin 4 receptor deficiency.